Merit Medical Systems (MMSI) Competitors

Merit Medical Systems (NASDAQ:MMSI) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, community ranking, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Which has higher valuation and earnings, MMSI or HAE?

Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.26B	3.74	$94.41M	$1.74	46.45
Haemonetics	$1.31B	3.72	$115.40M	$2.29	41.86

Is MMSI or HAE more profitable?

Haemonetics has a net margin of 8.98% compared to Merit Medical Systems' net margin of 7.94%. Haemonetics' return on equity of 22.25% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	7.94%	15.02%	8.83%
Haemonetics	8.98%	22.25%	9.73%

Does the media refer more to MMSI or HAE?

In the previous week, Haemonetics had 19 more articles in the media than Merit Medical Systems. MarketBeat recorded 29 mentions for Haemonetics and 10 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.89 beat Haemonetics' score of 0.67 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	8 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, MMSI or HAE?

Merit Medical Systems has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500.

Does the MarketBeat Community believe in MMSI or HAE?

Merit Medical Systems received 29 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 68.90% of users gave Merit Medical Systems an outperform vote while only 60.89% of users gave Haemonetics an outperform vote.

Company	Underperform	Outperform
Merit Medical Systems	Outperform Votes 412 68.90%	Underperform Votes 186 31.10%
Haemonetics	Outperform Votes 383 60.89%	Underperform Votes 246 39.11%

Do institutionals & insiders hold more shares of MMSI or HAE?

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 1.8% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Do analysts prefer MMSI or HAE?

Merit Medical Systems currently has a consensus target price of $92.78, suggesting a potential upside of 14.78%. Haemonetics has a consensus target price of $108.67, suggesting a potential upside of 13.36%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities analysts plainly believe Merit Medical Systems is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Haemonetics	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Merit Medical Systems beats Haemonetics on 10 of the 18 factors compared between the two stocks.